Earnings Per Share, Basic in USD/shares of Achilles Therapeutics plc from 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Achilles Therapeutics plc quarterly/annual Earnings Per Share, Basic history and change rate from 2020 to Q2 2024.
  • Achilles Therapeutics plc Earnings Per Share, Basic for the quarter ending 30 Jun 2024 was -0.41 USD/shares, a 2.38% increase year-over-year.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2023 was -1.74 USD/shares, a 4.4% increase from 2022.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2022 was -1.82 USD/shares, a 14.6% increase from 2021.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2021 was -2.13 USD/shares, a 93.2% increase from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 +$0.01 +2.38% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024
Q2 2023 $0 +$0.02 +4.55% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024
Q2 2022 $0 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$0.08 +4.4% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024
2022 -$2 +$0.31 +14.6% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024
2021 -$2 +$29.00 +93.2% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024
2020 -$31 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.